BGB-26808
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BGB-26808, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors [Phase 1]